This article details a novel framework leveraging electronic health records and drug-target predictions to enhance the accurate prediction of efficacy for repurposed heart failure therapies in clinical trials.
Most Recent Articles
Microbiota Metabolite 2-Methylisocitrate Modulates 5-FU Chemotherapy Efficacy
This article investigates how a specific metabolite from the cancer-associated microbiota can significantly modulate the effectiveness of chemotherapy, presenting a promising new direction for cancer treatment strategies
Precision Medicine for Obesity: Genetic Subtypes and Their Distinct Risk Profiles
New genetic research reveals specific variants that uncouple obesity from cardiometabolic comorbidities, providing biological insights for precision medicine approaches.
Statin Eligibility According to Atherosclerotic Cardiovascular Disease Risk in the US
Risk-based decision making forms the cornerstone of preventing atherosclerotic cardiovascular disease, directing appropriate interventions for patient health.
Assessing Mobile Integrated Health in Heart Failure: Limited Overall Impact on Outcomes
The Mighty-Heart trial found no significant overall benefit of adding mobile integrated health to a transitions of care coordinator for heart failure patients' 30-day readmissions or health status.